General
SHM - Chapter 3 - Save Our Children’s Sight Screening Day Protocol
SHM - Chapter 3 - Save Our Children’s Sight Vision Referral Letter
SHM - Chapter 3 - Save Our Children’s Sight Voucher Procedure
SHM - Chapter 4 - Emergency Asthma Algorithm
SHM - Chapter 4 - Nursing Delegation
SHM - Chapter 4 - Peak Flow Meter
SHM - Chapter 6 - Guidelines for Hypoglycemia
SHM - Chapter 9 - Public Health Authority Letter (2017)
SHM - Chapter 15 - Standing Orders Signature Page (2017)
SHM - Chapter 10 - Communicable Disease Flowchart
SHM - Chapter 10 - Notifiable Conditions Letter
SHM - Chapter 10 - Lice Identification Photos
SHM - Chapter 10 - Lice Management Flowchart
SHM - Chapter 10 - Tuberculosis Screening Guidelines
SHM - Chapter 14 - Child Depression Screen
SHM - Chapter 16 - Annual School Health Services Report
This memo to Licensed Non-Profit Producers explains that while the application period for new, third party manufactures in the Medical Cannabis Program remains closed, the Department of Health will start accepting requests for amended licenses from LNPPs who are not currently manufacturing for themselves and wish to do so.
This is the letter sent to the New Mexico Medical Society about current vacancies on the Medical Cannabis Program's medical advisory board.
Currently there is no evidence available supporting the administration of benzodiazepines in the pre-hospital setting by EMT- Intermediates in other jurisdictions; however, it may prove beneficial to allow EMT – Intermediates to administer benzodiazepines in the pre-hospital setting to avoid adverse outcomes related to delays in treatment.
This screening criteria is for use by public health offices to screen adults before providing vaccinations.